Genitourinary Radiology: Page 64

Prostate brachytherapy side effects self-resolve
By AuntMinnie.com staff writers
Most men who have permanent prostate brachytherapy treatment for early-stage prostate cancer experience urinary side effects, but symptoms resolve for the majority of patients within one year following completion of radiation treatment, according to a report published in the September issue of Urology.
September 10, 2009
Algeta, Bayer join forces
By AuntMinnie.com staff writers
Therapeutic radiopharmaceutical developer Algeta has inked an $800 million agreement with Bayer for the development and commercialization of its Alpharadin alpha-emitting pharmaceutical for treating bone metastases.
September 7, 2009
IGRT boosts outcomes for obese prostate cancer patients
By AuntMinnie.com staff writers
Image-guided radiation therapy (IGRT) may yield improved outcomes for moderately to severely obese prostate cancer patients, according to a study published in the September 1 issue of the International Journal of Radiation Oncology, Biology, Physics.
September 2, 2009
Resonant to unveil new Clarity version
By AuntMinnie.com staff writers
Ultrasound image-guided radiation therapy (IGRT) developer Resonant Medical will showcase the next generation of its Clarity IGRT system at next week's European Society for Therapeutic Radiology and Oncology annual meeting.
September 1, 2009
PET/CT may help detect recurring prostate cancer earlier
By AuntMinnie.com staff writers
PET/CT scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.
September 1, 2009
Higher urethral dose means more toxicity when treating prostate cancer
By Cynthia E. Keen
There's a direct relationship between radiation dose to the urethra and genitourinary toxicity in prostate cancer patients who receive both high-dose-rate brachytherapy and hypofractionated external-beam radiation therapy, Japanese researchers report in the International Journal of Radiation Oncology, Biology, Physics.
August 31, 2009
NJ rep turns up the heat in VA brachy probe
By AuntMinnie.com staff writers
A U.S. congressman is asking the U.S. Department of Veterans Affairs (VA) for a status update regarding the agency's investigation of treatment errors in its brachytherapy program for prostate cancer patients.
August 26, 2009
VMAT bests IMRT for prostate cancer treatment time
By Paula Gould
In terms of dosimetric accuracy, volumetric-modulated arc therapy (VMAT) is comparable to step-and-shoot intensity-modulated radiation therapy (IMRT), but VMAT cuts treatment time considerably, according to research from Memorial Sloan-Kettering Cancer Center.
August 23, 2009
2009 01 15 16 03 49 510 Med Phys Web Logo 100
6 more botched prostate brachytherapy cases at Philly VAMC
By AuntMinnie.com staff writers
Six more cases of botched brachytherapy treatment for veterans with prostate cancer performed at the Philadelphia Veterans Affairs Medical Center (VAMC) between 2002 and 2008 have been identified.
August 17, 2009
IsoRay nets FDA OK on seeds
By AuntMinnie.com staff writers
Medical isotope developer IsoRay Medical has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its Proxcelan cesium-131 brachytherapy seeds.
August 17, 2009
Invivo debuts MR prostate offerings
By AuntMinnie.com staff writers
MR technology provider Invivo has introduced an MR prostate package for analysis, planning, and interventional biopsy.
August 10, 2009
Congress eyes safety of VA prostate brachytherapy: Part 2
By Cynthia E. Keen
The radiation oncologist at the center of a scandal over prostate brachytherapy procedures performed at a Philadelphia Department of Veterans Affairs (VA) hospital found himself on the hot seat in hearings before the U.S. Congress on July 22.
August 9, 2009
Previous Page
Page 64 of 96
Next Page